New gout drug study: does food change how it works?
NCT ID NCT07346027
First seen Jan 17, 2026 · Last updated Jun 19, 2026 · Updated 21 times
Summary
This early-stage trial will test a new drug called F-02-2-Na, designed to lower high uric acid levels (which can cause gout). Twelve healthy adults will take the drug once on an empty stomach and once after a meal to see if food changes how the drug is absorbed. The main goal is to check safety and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERURICEMIA WITH OR WITHOUT GOUT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
F-02-2-Na (a drug for lowering uric acid)
What this could lead to
If successful, this study could help determine the best way to take F-02-2-Na (with or without food) for future trials in people with high uric acid or gout.
What could go wrong
This is a very early Phase 1 study with only 12 healthy people, so it won't show if the drug actually works for the disease. It only looks at safety and how food affects drug levels.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.